Long‐term effect of Roux‐en‐Y gastric bypass versus sleeve gastrectomy on reflux and Barrett's oesophagus: a randomized controlled trial
ANZ Journal of Surgery · 2025
DOI: 10.1111/ans.19369 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift ANZ Journal of Surgery, 2025. Verfasst von Young Min Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, North Shore Hospital, Waitemata District Health Board, Auckland, New Zealand. Hauptthemen laut MEDLINE: Gastric Bypass, Barrett Esophagus, Gastroesophageal Reflux, Gastrectomy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Johnson & Johnson Innovative Medicine, Medtronic Foundation, Auckland Medical Research Foundation.
Abstract (Originalsprache)
Background
Laparoscopic sleeve gastrectomy (LSG) is a potentially refluxogenic operation while Laparoscopic Roux‐en‐Y Gastric Bypass (LRYGB) is regarded as an anti‐reflux procedure. The aim of this study is to compare long‐term incidence of Barrett's Oesophagus (BO) and gastroesophageal reflux disease (GORD) following LSG and LRYGB.
Methods
Participants of a double‐blinded randomized controlled trial comparing banded LRYGB and LSG for remission of type 2 diabetes were contacted to take part. A gastroscopy was performed. Primary outcome was endoscopic and histologic evidence of BO. Secondary outcomes included reflux and regurgitation scores, presence of oesophagitis, proton‐pump inhibitor (PPI) usage, Body Mass Index (BMI), and percentage excess weight loss (%EWL).
Results
Forty‐eight of 109 patients were enrolled into the study (LSG 26 vs. LRYGB 22). Mean follow‐up was 7.5 years for the LSG group, and 7.4 years for the RYGB group ( P = 0.22). 8 LSG patients had BO while 3 LRYGB patients had BO (30.8%vs13.6%, P = 0.19). There was no significant difference in the mean reflux (8.1 ± 9.4(0–36) vs. 9.3 ± 8.8(0–34), P = 0.47) and regurgitation scores (7.7 ± 6.9(0–22) vs. 11.5 ± 10.5(0–44), P = 0.23) for LSG versus LRYGB patients or between those with and without BO. PPI usage before and after surgery was 6/26 (23.1%) versus 13/26 (50.0%) and 8/22 (36.4%) versus 12/22 (54.5%) for LSG and LRYGB patients respectively. PPI usage in patients with and without BO was 7/11 versus 18/37. EWL was significantly greater ( P = 0.0013) in the LRYGB group (74.8 ± 28.1%) compared to LSG group (49.7 ± 18.7%).
Conclusions
Long‐term incidence of BO trended towards but was not significantly higher for LSG compared to LRYGB group. We support routine endoscopic surveillance for bariatric patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, North Shore Hospital, Waitemata District Health Board, Auckland, New Zealand.
- Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
ORCID-Profile: Young Min Lee, Ahmed Barazanchi
Förderung
- Johnson & Johnson Innovative Medicine
- Medtronic Foundation
- Auckland Medical Research Foundation
Zitieren
APA
Lee, Y. M., Barazanchi, A., Robertson, J., Murphy, R., & Booth, M. W. C. (2025). Long‐term effect of Roux‐en‐Y gastric bypass versus sleeve gastrectomy on reflux and Barrett's oesophagus: a randomized controlled trial. ANZ Journal of Surgery. https://doi.org/10.1111/ans.19369
Vancouver
Lee YM, Barazanchi A, Robertson J, Murphy R, Booth MWC. Long‐term effect of Roux‐en‐Y gastric bypass versus sleeve gastrectomy on reflux and Barrett's oesophagus: a randomized controlled trial. ANZ Journal of Surgery. 2025. doi:10.1111/ans.19369
BibTeX
@article{Lee2025,
author = {Lee, Young Min and Barazanchi, Ahmed and Robertson, Jason and Murphy, Rinki and Booth, Michael W C},
title = {Long‐term effect of Roux‐en‐Y gastric bypass versus sleeve gastrectomy on reflux and Barrett's oesophagus: a randomized controlled trial},
journal = {ANZ Journal of Surgery},
year = {2025},
doi = {10.1111/ans.19369}
}
EUVIMED